Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. [electronic resource]
Producer: 20200526Description: 106215 p. digitalISSN:- 1873-5835
- Adult
- Aged
- Benzylamines
- Costs and Cost Analysis
- Cyclams
- Female
- Health Care Costs
- Hematopoietic Stem Cell Mobilization -- economics
- Hematopoietic Stem Cell Transplantation -- economics
- Heterocyclic Compounds -- administration & dosage
- Hospitalization -- economics
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- diagnosis
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.